P Kronqvist
Overview
Explore the profile of P Kronqvist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Korpinen K, Autere T, Tuominen J, Loyttyniemi E, Eigeliene N, Talvinen K, et al.
Breast Cancer Res Treat
. 2024 Dec;
PMID: 39739270
Purpose: Due to biological heterogeneity of breast carcinoma, predicting the individual response to neoadjuvant treatment (NAT) is complex. Consequently, there are no comprehensive, generally accepted practices to guide post-treatment follow-up....
2.
Vihervuori H, Korpinen K, Autere T, Repo H, Talvinen K, Kronqvist P
Breast Cancer Res Treat
. 2022 Oct;
196(3):471-482.
PMID: 36261751
Purpose: Triple-negative breast cancer (TNBC) is an aggressive disease lacking specific biomarkers to guide treatment decisions. We evaluated the combined prognostic impact of clinical features and novel biomarkers of cell...
3.
Vihervuori H, Autere T, Repo H, Kurki S, Kallio L, Lintunen M, et al.
J Cancer Res Clin Oncol
. 2019 Sep;
145(12):3105-3114.
PMID: 31562550
Purpose: Tumor inflammatory response was evaluated as a prognostic feature in triple-negative breast cancer (TNBC) and compared with the clinical prognosticators of breast cancer and selected biomarkers of cancer cell...
4.
Gurvits N, Repo H, Loyttyniemi E, Nykanen M, Anttinen J, Kuopio T, et al.
Cell Oncol (Dordr)
. 2016 Mar;
39(4):319-31.
PMID: 26984614
Purpose: Securin belongs to a class of cell cycle regulators that prevent metaphase-to-anaphase transition until sister chromatid separation is complete. Evidence is accumulating that securin has a prognostic impact on...
5.
Karra H, Repo H, Ahonen I, Loyttyniemi E, Pitkanen R, Lintunen M, et al.
Br J Cancer
. 2014 May;
110(12):2905-13.
PMID: 24853182
Background: Cdc20 is an essential component of cell division and responsible for anaphase initiation regulated by securin degradation. Cdc20 function is strongly regulated by the spindle assembly checkpoint to ensure...
6.
Jin S, Mutvei A, Chivukula I, Andersson E, Ramskold D, Sandberg R, et al.
Oncogene
. 2012 Nov;
32(41):4892-902.
PMID: 23178494
Notch signaling is frequently hyperactivated in breast cancer, but how the enhanced signaling contributes to the tumor process is less well understood. In this report, we identify the proinflammatory cytokine...
7.
Talvinen K, Tuikkala J, Nykanen M, Nieminen A, Anttinen J, Nevalainen O, et al.
J Cancer Res Clin Oncol
. 2010 Feb;
136(9):1377-87.
PMID: 20151151
Purpose: The study focuses on p120catenin, a regulator of cell adhesion, which has previously been described in many malignancies and suggested with a role in invasion and metastatic behaviour. In...
8.
Talvinen K, Karra H, Hurme S, Nykanen M, Nieminen A, Anttinen J, et al.
Br J Cancer
. 2009 Aug;
101(6):1005-10.
PMID: 19690544
Background: Securin is a recently recognised oncogene with multiple known functions in initiation, progression and cell cycle regulation in several malignant diseases, including breast carcinoma. Methods: In this paper, the...
9.
Talvinen K, Tuikkala J, Nevalainen O, Rantanen A, Hirsimaki P, Sundstrom J, et al.
Br J Cancer
. 2008 Jul;
99(2):335-40.
PMID: 18594525
We introduce a new proliferation marker, securin (pituitary tumour-transforming 1 (PTTG1)), analysed in invasive ductal breast carcinomas by cDNA microarrays and immunohistochemistry. In cDNA microarray of a total of 4000...
10.
Kronqvist P, Makinen J, Ranne S, Kaapa P, Vainio O
Med Teach
. 2008 Feb;
29(8):836-8.
PMID: 18236282
Background: In order to meet the changing needs of health care, the University of Turku has introduced a graduate entry programme aimed at students with previous education and experience in...